ISSN 2052-9643
Now Accepting Submissions
..................................................................................
OA Tissue Engineering is a multidisciplinary open access 'peer reviewed' journal that publishes basic and clinical research concerning all aspects of tissue engineering:
Biomaterials Bioimplants & Medical Devices
Biofilms, Bioimaging & Biosensors
Fibres & Tissue Scaffolds
Tissue Engineering & Modelling
Artificial Organs & Tissue Interfaces
Biomaterials, Blood, Cells, Tissues & Organs
Regenerative Medicine Clinical Performance
OA Tissue Engineering is committed to publishing high quality 'peer reviewed' manuscripts that illustrate the most important and 'cutting edge' developments in all areas of tissue engineering.
We will facilitate article submission, rapid article quality assurance through 'peer review', article formatting and processing to a final product which will allow high visibility, impact and provoke debate.
This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, JournalSeek, CrossRef, EZB Nutzeranfragen, RoMEO, AcademicKeys, CNKI, J-Gate
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
The Association for Medical Ethics promotes the care of patients absent of any consideration of financial gain or loss based on choice of surgical equipment, implant, manufacturer, hospital or surgery center.
OAPL has adopted the Ethical Rules of Disclosure of the Association for Medical Ethics for all its journals.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Dembinski D, Oren L, Gutmark E, Khosla S. Biomechanical measurements of vocal fold elasticity. OA Tissue Engineering 2014 Feb 22;2(1):3.
High Impactvan Spreeuwel ACC, Bax NAM, Bouten CVC. The relevance of extracellular matrix structure and composition in engineering the diseased cardiac microenvironment. OA Tissue Engineering 2014 Jan 18;2(1):2.
High ImpactLi X, Mao HQ. Bioengineering endogenous neural stem cells for central nervous system regeneration. OA Tissue Engineering 2014 Jan 18;2(1):1.
High ImpactKristj?nsson B, Honsawek S. Current trends of stem cell-based approaches for knee osteoarthritis. OA Tissue Engineering 2013 Jun 01;1(1):7.
High ImpactChan KH, Zhuo S, Ni M. Natural and synthetic peptide-based biomaterials for bone tissue engineering. OA Tissue Engineering 2013 May 01;1(1):6.
High ImpactLee YJ, Kim GM. Tunable electrospun scaffolds on cell behaviour for tissue regeneration and drug delivery system. OA Tissue Engineering 2013 May 01;1(1):5.
High ImpactRicci C, Moroni L, Danti S. Cancer tissue engineering?new perspectives in understanding the biology of solid tumours?a critical review. OA Tissue Engineering 2013 Apr 01;1(1):4.
High ImpactLi Z, He C, Xiao J, Chen ZY. Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke. OA Tissue Engineering 2013 Apr 01;1(1):3.
High ImpactHuang HS, Hsu SH. Current advances of stem cell-based approaches to tissue-engineered vascular grafts. OA Tissue Engineering 2013 Mar 01;1(1):2.
High ImpactAlmelkar SI, Kadam SS, Diwate S, Chaukar A, Bhonde RR, Patwardhan AM. Re-endothelialization of biological tissue-engineered conduits and scaffold for its potential use in bioprosthesis. OA Tissue Engineering 2013 Mar 01;1(1):1.
High ImpactLi Z, He C, Xiao J, Chen ZY. Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke. OA Tissue Engineering 2013 Apr 01;1(1):3.
High ImpactRicci C, Moroni L, Danti S. Cancer tissue engineering?new perspectives in understanding the biology of solid tumours?a critical review. OA Tissue Engineering 2013 Apr 01;1(1):4.
High ImpactHuang HS, Hsu SH. Current advances of stem cell-based approaches to tissue-engineered vascular grafts. OA Tissue Engineering 2013 Mar 01;1(1):2.
High ImpactAlmelkar SI, Kadam SS, Diwate S, Chaukar A, Bhonde RR, Patwardhan AM. Re-endothelialization of biological tissue-engineered conduits and scaffold for its potential use in bioprosthesis. OA Tissue Engineering 2013 Mar 01;1(1):1.
High Impactvan Spreeuwel ACC, Bax NAM, Bouten CVC. The relevance of extracellular matrix structure and composition in engineering the diseased cardiac microenvironment. OA Tissue Engineering 2014 Jan 18;2(1):2.
High ImpactKristj?nsson B, Honsawek S. Current trends of stem cell-based approaches for knee osteoarthritis. OA Tissue Engineering 2013 Jun 01;1(1):7.
High ImpactChan KH, Zhuo S, Ni M. Natural and synthetic peptide-based biomaterials for bone tissue engineering. OA Tissue Engineering 2013 May 01;1(1):6.
High ImpactDembinski D, Oren L, Gutmark E, Khosla S. Biomechanical measurements of vocal fold elasticity. OA Tissue Engineering 2014 Feb 22;2(1):3.
High ImpactLi X, Mao HQ. Bioengineering endogenous neural stem cells for central nervous system regeneration. OA Tissue Engineering 2014 Jan 18;2(1):1.
High ImpactLee YJ, Kim GM. Tunable electrospun scaffolds on cell behaviour for tissue regeneration and drug delivery system. OA Tissue Engineering 2013 May 01;1(1):5.
High ImpactDembinski D, Oren L, Gutmark E, Khosla S. Biomechanical measurements of vocal fold elasticity. OA Tissue Engineering 2014 Feb 22;2(1):3.
High Impactvan Spreeuwel ACC, Bax NAM, Bouten CVC. The relevance of extracellular matrix structure and composition in engineering the diseased cardiac microenvironment. OA Tissue Engineering 2014 Jan 18;2(1):2.
High ImpactLi X, Mao HQ. Bioengineering endogenous neural stem cells for central nervous system regeneration. OA Tissue Engineering 2014 Jan 18;2(1):1.
High ImpactKristj?nsson B, Honsawek S. Current trends of stem cell-based approaches for knee osteoarthritis. OA Tissue Engineering 2013 Jun 01;1(1):7.
High ImpactChan KH, Zhuo S, Ni M. Natural and synthetic peptide-based biomaterials for bone tissue engineering. OA Tissue Engineering 2013 May 01;1(1):6.
High ImpactLee YJ, Kim GM. Tunable electrospun scaffolds on cell behaviour for tissue regeneration and drug delivery system. OA Tissue Engineering 2013 May 01;1(1):5.
High ImpactRicci C, Moroni L, Danti S. Cancer tissue engineering?new perspectives in understanding the biology of solid tumours?a critical review. OA Tissue Engineering 2013 Apr 01;1(1):4.
High ImpactLi Z, He C, Xiao J, Chen ZY. Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke. OA Tissue Engineering 2013 Apr 01;1(1):3.
High ImpactHuang HS, Hsu SH. Current advances of stem cell-based approaches to tissue-engineered vascular grafts. OA Tissue Engineering 2013 Mar 01;1(1):2.
High ImpactAlmelkar SI, Kadam SS, Diwate S, Chaukar A, Bhonde RR, Patwardhan AM. Re-endothelialization of biological tissue-engineered conduits and scaffold for its potential use in bioprosthesis. OA Tissue Engineering 2013 Mar 01;1(1):1.
High ImpactRead about the
OAPL (UK) Code of Conduct for Editors
OAPL (UK) Press Centre- Publishing Director
OAPL (UK) and its journals support the following reporting guidelines for specific study designs:
CONSORT: Consolidated Standards of Reporting Trials
STARD: STAndards for the Reporting of Diagnostic accuracy studies
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
STROBE: STrengthening the Reporting of OBservational studies in Epidemiology
MOOSE: Meta-analysis of Observational Studies in Epidemiology
MIBBI: Minimum Information for Biological and Biomedical Investigations
ICTRP: International Clinical Trials Registry Platform
PROSPERO: International prospective register of systematic reviews
Copyright © 2013 - 2020 OAPL (UK)